The Influence of 18F-Fluorodeoxyglucose Positron Emission Tomography/computed Tomography on the N- and M-staging and Subsequent Clinical Management of Intrahepatic Cholangiocarcinoma
Youpei Lin,Huanhuan Chong,Guohe Song,Chenhao Zhang,Liangqing Dong,Ling Aye,Fei Liang,Shuaixi Yang,Mengsu Zeng,Guangyu Ding,Shu Zhang,Jieyi Shi,Aiwu Ke,Xiaoying Wang,Jian Zhou,Jia Fan,Qiang Gao
DOI: https://doi.org/10.21037/hbsn-21-25
2022-01-01
HepatoBiliary Surgery and Nutrition
Abstract:Background: Intrahepatic cholangiocarcinoma (ICC) is a highly metastatic cancer. F-18-fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) enables sensitive tumor and metastasis detection. Our aim is to evaluate the influence of pre-treatment PET/CT on the N-and M-staging and subsequent clinical management in ICC patients. Methods: Between August 2010 and August 2018, 660 consecutive ICC patients, without prior anti-tumor treatments nor other malignancies, were enrolled. The diagnostic performance of PET/CT on the N-and M-staging was compared with conventional imaging, and the preoperative staging accuracy and treatment re-allocation by PET/CT were retrospectively calculated. Survival difference was compared between patients receiving PET/CT or not after propensity score matching. Results: Patients were divided into group A (n=291) and group B (n=369) according to whether PET/CT was performed. Among 291 patients with both PET/CT and conventional imaging for staging in group A, PET/CT showed significantly higher sensitivity (83.0% vs. 70.5%, P=0.001), specificity (88.3% vs. 74.9%, P<0.001) and accuracy (86.3% vs. 73.2%, P<0.001) than conventional imaging in diagnosing regional lymph node metastasis, as well as higher sensitivity (87.8% vs. 67.6%, P<0.001) and accuracy (93.5% vs. 89.3%, P=0.023) in diagnosing distant metastasis. Overall, PET/CT improved the accuracy of preoperative staging from 60.1% to 71.8% (P<0.001), and modified clinical treatment strategy in 5.8% (17/291) of ICC patients, with unique roles in different TNM stages. High tumor-to-non-tumor ratio (TNR) predicted poor overall survival [hazard ratio (HR) 2.17, 95% confidence interval (CI): 1.49-3.15, P<0.001]. Furthermore, patients performing PET/CT had longer overall survival compared with those without PET/CT (HR 0.74, 95% CI: 0.58-0.93, P=0.011) after propensity score matching. Conclusions: PET/CT was valuable for diagnosing regional lymph node metastasis and distant metastasis in ICC patients, and facilitated accurate tumor staging and optimal treatment allocation.